ISRCTN77773974已完成不适用
A randomised study of continuous subcutaneous insulin infusion (CSII) therapy compared to conventional bolus insulin treatment in preschool aged children with Type 1 diabetes
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 个研究点目标入组 20 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •20 children <5 years with type 1 diabetes
排除标准
- •Does not match inclusion criteria
研究者
相似试验
进行中（未招募）
1 期
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 DiabetesDiabetes Mellitus, Type 1EUCTR2010-024054-11-BEovo Nordisk A/S506
已完成
3 期
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 Diabetes.Diabetes type 110018424NL-OMON43891ovo Nordisk35
进行中（未招募）
1 期
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 DiabetesDiabetes Mellitus, Type 1EUCTR2010-024054-11-FRovo Nordisk A/S472
进行中（未招募）
1 期
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 DiabetesMedDRA version: 20.0 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861Diabetes Mellitus, Type 1EUCTR2010-024054-11-GBovo Nordisk A/S472
进行中（未招募）
1 期
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 DiabetesDiabetes Mellitus, Type 1EUCTR2010-024054-11-NLovo Nordisk A/S506